Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › rifabutin

rifabutin

2 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials of rifabutin

9 trials tracked of rifabutin: 1 in phase 3 or 4.

9Trials tracked
1Phase 3 & 4
0Recruiting
0With published results
Phase distribution
Phase 3 1 Phase 2 2 Phase 1 4 Other / NA 2
  1. Phase 3 A Study of Bedaquiline Administered as Part of a Treatment Regimen With Clarithromycin and Ethambutol in Adult Patients With Treatment-refractory Mycobacterium Avium Complex-lung Disease (MAC-LD) Completed
  2. Phase 2 Assessing PA-824 for Tuberculosis (the APT Trial) Completed
  3. Phase 2 A Clinical Trial of the Safety, Pharmacokinetics and Hematologic Effects of Imatinib on Myelopoiesis in Adults When Given With and Without Isoniazid and Rifabutin Completed
  4. Phase 1 The Effect of Moderate CYP3A Inducer Rifabutin on the Pharmacokinetics of Zanubrutinib in Healthy Males Completed
  5. Phase 1 Effect of Rifabutin on the Pharmacokinetics of Oral Cabotegravir in Healthy Subjects Completed
  6. Phase 1 Drug Interaction Study Completed
Show 3 more trials
  1. Phase 1 A Drug Interaction Study Investigating the Effect of Rifabutin on the Pharmacokinetics of Maraviroc Completed
  2. N/A Safety And Efficacy Of Rifabutin In HIV Patients Completed
  3. N/A Safety And Efficacy Of Rifabutin In Patients For Non-HIV Patients Completed

Showing the 9 most-cited and recently-updated of 9 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Bismuth quadruple and concomitant regimens achieve >85% H. pylori eradication amid rising clarithromycin resistance
Gastroenterology Sys. Review
Bismuth quadruple and concomitant regimens achieve >85% H. pylori eradication amid rising clarithromycin resistance H. pylori treatments failing as resistance grows, review finds
This narrative review synthesizes current H. pylori eradication strategies, noting that clarithromycin resistance exceeds 15%-20% in most re…
Clarithromycin resistance now tops 15-20% in most regions, but bismuth quadruple and other combos still clear the bug over 85% of the time.
Frontiers Jul 29, 2026
BV100 (rifabutin for infusion) showed dose-proportional pharmacokinetics and safety in healthy volunteers
Infectious Disease RCT
BV100 (rifabutin for infusion) showed dose-proportional pharmacokinetics and safety in healthy volunteers A New IV Drug Targets the Hardest Hospital Infections to Treat
This Phase 1 randomized controlled trial evaluated the pharmacokinetics, safety, and tolerability of BV100 (rifabutin for infusion) in healt…
A reformulated intravenous version of the antibiotic rifabutin appears safe in healthy volunteers and may give doctors a new tool for treati…
Apr 13, 2026